Feb 11, 2020 6:30am EST ProMIS Neurosciences to Participate in Noble Capital Markets 16th Annual Investor Conference
Jan 29, 2020 6:30am EST ProMIS Neurosciences Data for Alzheimer’s Disease Program Targeting Tau Accepted for Presentation at Tau2020
Jan 15, 2020 6:30am EST ProMIS Neurosciences Appoints Dr. José Luis Molinuevo to its Scientific Advisory Board
Jan 09, 2020 6:30am EST ProMIS Neurosciences to present at Sachs 3rd Annual Neuroscience Innovation Forum
Jan 08, 2020 6:30am EST ProMIS Neurosciences issues Chairman’s Update detailing positive outlook for Alzheimer’s disease therapy, pipeline in 2020
Dec 10, 2019 7:30am EST ProMIS Neurosciences’ Alzheimer’s disease program takes on renewed significance following positive aducanumab news
Dec 05, 2019 12:50pm EST Aducanumab is good; next generation Alzheimer’s disease therapies will be better